09/01/2022
Hi everyone! We hope you’re having a great week.
We are excited to announce that we are starting a new Phase 3 research study for patients with knee pain from osteoarthritis of the knee. This is a clinic based study that involves one injection to the painful knee. The investigational study product is a sterile amniotic tissue product.
This study is open to patients 18 years of age or older with mild to severe arthritis of the knee.
If you’ve recently had a steroid injection or visco/gel injection in your knee, there is a brief waiting period before you can join the study. Please reach out to us for more details.
This is a nationwide study designed specifically for arthritis patients. Some medical history is excluded from this trial including a diagnosis of rheumatoid arthritis, gout, fibromyalgia, or knee surgery within 12 months of joining the study. Additionally, the sponsor is excluding patients on regular blood thinners for issues such as atrial fibrillation.
If you join the study, you do not need to have health insurance as all study procedures are provided at no charge. If you are interested in learning more about the study, please call 941-552-7875 (for the research office at KWOC) or send us an inbox message here. Thanks!
Note: The wording of this post received Institution Review Board (IRB) approval.